IP Library Patent Application 12934791
Patent Application
App. No. 12/934,791

REINFORCED TISSUE GRAFT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/934,791
Abstract

A biocompatible tissue graft is provided. The tissue graft includes an extracellular matrix patch and a means for reinforcing the patch.

Claims (28)

1 . A biocompatible tissue graft comprising:

an extracellular matrix patch; and

a means for reinforcing the patch to mitigate tearing and/or improve fixation retention of the patch, wherein the reinforcing means comprises at least one fiber stitched into the patch in a reinforcement pattern.

2 . (canceled)

3 . The tissue graft of claim 1 , wherein the reinforcing means comprises fibers stitched into the patch in a concentric pattern.

4 . The tissue graft of claim 3 , wherein the reinforcing means comprises multiple concentric patterns of fibers stitched into the patch.

5 . The tissue graft of claim 1 , wherein the reinforcing means comprises fibers stitched into the patch in a cross-hatched configuration.

6 . The tissue graft of claim 1 , wherein the fiber is selected from the group consisting of silk, sericin free silk, modified silk fibroins, polyesters like polyglycolic acid (PGA), polylactic acid (PLA), polylactic-co-glycolic acid (PLGA), polyethyleneglycol (PEG), polyhydroxyalkanoates (PHA), polyethylene terephthalate (PET), polyethylene (PE), ultra-high molecular weight polyethylene (UHMWPE), blends thereof, and copolymers thereof.

7 . The tissue graft of claim 1 , wherein at least one of the patch and the fiber is modified to improve adhesion between the patch and the fiber.

8 . The tissue graft of claim 1 , wherein the patch is decellularized.

9 . The tissue graft of claim 1 , wherein the patch further comprises at least one progenitor cell.

10 . The tissue graft of claim 1 , wherein the patch further comprises at least one biologically active molecule selected from the group consisting of enzymes, hormones, cytokines, colony-stimulating factors, vaccine antigens, antibodies, clotting factors, angiogenesis factors, regulatory proteins, transcription factors, receptors, and structural proteins and combinations thereof.

11 . A biocompatible tissue graft comprising:

a fascia patch; and

at least one fiber stitched into the patch in a reinforcement pattern to mitigate tearing and/or improve fixation retention of the patch.

12 . The tissue graft of claim 11 , wherein the reinforcing means comprises fibers stitched into the patch in a concentric pattern.

13 . The tissue graft of claim 12 , wherein the reinforcing means comprises multiple concentric patterns of fibers stitched into the patch.

14 . The tissue graft of claim 11 , wherein the reinforcing means comprises fibers stitched into the patch in a cross-hatched configuration.

15 . The tissue graft of claim 11 , wherein the fiber is selected from the group consisting of silk, sericin free silk, modified silk fibroins, polyesters like polyglycolic acid (PGA), polylactic acid (PLA), polylactic-co-glycolic acid (PLGA), polyethyleneglycol (PEG), polyhydroxyalkanoates (PHA), polyethylene terephthalate (PET), polyethylene (PE), ultra-high molecular weight polyethylene (UHMWPE), blends thereof, and copolymers thereof.

16 . The tissue graft of claim 11 , wherein at least one of the patch and the fiber is modified to improve adhesion between the patch and the fiber.

17 . The tissue graft of claim 11 , wherein the patch is decellularized.

18 . The tissue graft of claim 11 , wherein the patch further comprises at least one progenitor cell.

19 . The tissue graft of claim 11 , wherein the patch further comprises at least one biologically active molecule selected from the group consisting of enzymes, hormones, cytokines, colony-stimulating factors, vaccine antigens, antibodies, clotting factors, angiogenesis factors, regulatory proteins, transcription factors, receptors, and structural proteins.

20 - 29 . (canceled)

30 . A method for repairing tissue in a subject comprising:

administering to the tissue a tissue graft comprising an extracellular matrix patch and at least one fiber stitched into the patch to mitigate tearing and/or improve fixation retention of the patch.

31 . The method of claim 30 , wherein the step of administering the tissue graft comprises securing the tissue graft in or on recipient tissue.

32 . The method of claim 31 , wherein the step of securing the tissue graft in or on recipient tissue comprises suturing, stitching, or screwing.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2010
From: DERWIN, KATHLEEN A.; AURORA, AMIT; IANNOTTI, JOSEPH P.; MCCARRON, JESSE A.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 025186/0055 →